Arthur David J. 4
4 · Salarius Pharmaceuticals, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-01-03+20,000→ 33,719 total
Holdings
- 552(indirect: By daughter)
Common Stock
- 564(indirect: By son)
Common Stock
Footnotes (1)
- [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 25% of the shares of restricted stock will vest on January 2, 2024, and 1/36 of the remaining shares of restricted stock will vest on monthly anniversary thereafter.